The biosynthesis of selenocysteine is a multi-step process that involves several key enzymes and cofactors. The process begins with the aminoacylation of tRNA(Sec) with serine by seryl-tRNA synthetase. This serine is then phosphorylated by O-phosphoseryl-tRNA kinase (PSTK) to form O-phosphoseryl-tRNA(Sec). The final step in the biosynthesis is catalyzed by SepSecS, which converts O-phosphoseryl-tRNA(Sec) to selenocysteinyl-tRNA(Sec) through a tRNA-dependent mechanism .
SepSecS operates through a pyridoxal phosphate-dependent mechanism. The enzyme forms a complex with tRNA(Sec), phosphoserine, and thiophosphate. The binding of tRNA(Sec) to SepSecS induces a conformational change in the enzyme’s active site, allowing the phosphoserine attached to tRNA(Sec) to be properly oriented for the reaction to occur. This reaction results in the formation of selenocysteinyl-tRNA(Sec), which is then used in the synthesis of selenoproteins .
The crystal structure of human SepSecS in complex with tRNA(Sec) has provided significant insights into the enzyme’s function. The structure reveals that two tRNA(Sec) molecules bind to each SepSecS tetramer through their 13-base pair acceptor-TPsiC arm. This binding is essential for the proper orientation and catalysis of the reaction .
Selenoproteins, which contain selenocysteine at their active sites, play critical roles in various biological processes, including antioxidant defense, thyroid hormone metabolism, and redox regulation. The proper functioning of SepSecS is therefore essential for the synthesis of these vital proteins and for maintaining cellular homeostasis .
Recombinant human SepSecS is produced using advanced biotechnological methods, allowing for the study of its structure and function in detail. This recombinant enzyme is used in various research applications to understand the mechanisms of selenocysteine biosynthesis and the role of selenoproteins in human health and disease .